Apex Medichem Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 08-12-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 27.40 Cr
as on 08-12-2024
- Satisfied Charges ₹ 52.97 Cr
as on 08-12-2024
- Revenue 137.84%
(FY 2022)
- Profit 115.30%
(FY 2022)
- Ebitda -13.71%
(FY 2022)
- Net Worth 54.22%
(FY 2022)
- Total Assets -3.86%
(FY 2022)
About Apex Medichem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹27.40 Cr. The company has closed loans amounting to ₹52.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
Archana Gondhalekar, Anjali Nagapurkar, and Saurabh Gondhalekar serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PTC152123
- Company No.
152123
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2005
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Apex Medichem Private Limited offer?
Apex Medichem Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antiepileptic Drugs.
Who are the key members and board of directors at Apex Medichem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Gondhalekar  | Director | 05-Mar-2021 | Current |
| Anjali Nagapurkar | Director | 01-Jul-2021 | Current |
| Saurabh Gondhalekar | Director | 05-Mar-2021 | Current |
Financial Performance of Apex Medichem.
Apex Medichem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 137.84% increase. The company also saw a substantial improvement in profitability, with a 115.3% increase in profit. The company's net worth Soared by an impressive increase of 54.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apex Medichem?
In 2022, Apex Medichem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Camp Pharma Private LimitedActive 5 years 4 monthsArchana Gondhalekar and Saurabh Gondhalekar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Nov 2022 | ₹13.80 Cr | Open |
Others Creation Date: 15 Oct 2022 | ₹13.60 Cr | Open |
Janata Sahakari Bank Ltd Pune Creation Date: 24 Jul 2015 | ₹5.00 M | Satisfied |
How Many Employees Work at Apex Medichem?
Apex Medichem has a workforce of 22 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Medichem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Medichem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
